24 July 2018 - The White House has been quick to claim credit for numerous drug companies’ decisions to back off planned price hikes for the remainder of 2018.
But such crowing from the Trump administration has not sat well with Democrats, who this week unveiled a pair of bills aimed at lowering prescription drug costs.